ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY

This adverse event was reported 215 times

These drugs are most commonly taken by patients reporting ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY:

# Drug Count
0 METHOTREXATE SODIUM 186
1 METHOTREXATE 179
2 ADALIMUMAB 177
3 ETANERCEPT 177
4 PREDNISONE 176
5 SULFASALAZINE 176
6 TOCILIZUMAB 175
7 LEFLUNOMIDE 172
8 TOFACITINIB 172
9 ABATACEPT 171
See all common drugs associated with ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY

ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 CAFFEINE CITRATE 88 0.0711
1 HYDROCORTISONE PROBUTATE 5 0.0685
2 TETRAHYDROZOLINE HYDROCHLORIDE 4 0.0563
3 200 WET WIPES 25 0.0476
4 CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE 15 0.0469
5 TRIPROLIDINE HYDROCHLORIDE 1 0.0303
6 DICLOFENAC POTASSIUM TABLETS 87 0.0269
7 PSEUDOEPHEDRINE HYDROCHLORIDE 127 0.0239
8 PSEUDOEPHEDRINE HCL 127 0.0202
9 CORTISONE ACETATE 143 0.0191
See all drugs enriched for association with ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY

ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Endoglycosidase [EPC] 7 0.0026
1 Antirheumatic Agent [EPC] 172 0.0019
2 Interleukin-6 Receptor Antagonist [EPC] 179 0.0018
3 Aminosalicylate [EPC] 176 0.0017
4 Interleukin-12 Antagonist [EPC] 125 0.0016
5 Selective T Cell Costimulation Modulator [EPC] 171 0.0016
6 Histamine-1 Receptor Antagonist [EPC] 47 0.0013
7 Interleukin-23 Antagonist [EPC] 125 0.0010
8 Methylxanthine [EPC] 33 0.0008
9 Interleukin-17A Antagonist [EPC] 115 0.0008
See all drug classes enriched for association with ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY